01P — Medpace Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual income statement for Medpace Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	861	926	1,142	1,460	1,886
Cost of Revenue
Gross Profit	246	279	328	432	525
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	734	759	944	1,181	1,549
Operating Profit	127	167	199	279	337
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	125	169	202	283	336
Provision for Income Taxes
Net Income After Taxes	100	145	182	245	283
Net Income Before Extraordinary Items
Net Income	100	145	182	245	283
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	100	145	181	245	283
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.67	3.84	4.81	7.28	8.88